Etin-Osa Osa to Female
This is a "connection" page, showing publications Etin-Osa Osa has written about Female.
Connection Strength
0.054
-
Osa EO, DeWyngaert K, Roses D, Speyer J, Guth A, Axelrod D, Fenton Kerimian M, Goldberg JD, Formenti SC. Prone breast intensity modulated radiation therapy: 5-year results. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):899-906.
Score: 0.026
-
Bozza C, Puglisi F, Lambertini M, Osa EO, Manno M, Del Mastro L. Anti-Mullerian hormone: determination of ovarian reserve in early breast cancer patients. Endocr Relat Cancer. 2014 Feb; 21(1):R51-65.
Score: 0.006
-
Bozza C, Osa EO, Puglisi F. Primary therapy in breast cancer: what have we learned from landmark trials? Womens Health (Lond). 2013 Nov; 9(6):583-93.
Score: 0.006
-
Bonotto M, Bozza C, Di Loreto C, Osa EO, Poletto E, Puglisi F. Making capecitabine targeted therapy for breast cancer: which is the role of thymidine phosphorylase? Clin Breast Cancer. 2013 Jun; 13(3):167-72.
Score: 0.006
-
Hitchen CJ, Osa EO, Dewyngaert JK, Chang J, Narayana A. Dose to craniofacial region through portal imaging of pediatric brain tumors. J Appl Clin Med Phys. 2012 Jan 05; 13(1):3385.
Score: 0.005
-
Ge Y, Zohrabian VM, Osa EO, Xu J, Jaggi H, Herbert J, Haacke EM, Grossman RI. Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 Tesla. J Magn Reson Imaging. 2009 May; 29(5):1190-4.
Score: 0.005